|
C1ORF107 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.142200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.286140E-02 |
| Normal-vs-Stage2 |
4.183700E-03 |
| Normal-vs-Stage3 |
1.471580E-01 |
| Normal-vs-Stage4 |
3.416000E-01 |
| Stage1-vs-Stage2 |
3.128200E-01 |
| Stage1-vs-Stage3 |
2.597800E-01 |
| Stage1-vs-Stage4 |
2.460600E-01 |
| Stage2-vs-Stage3 |
1.001980E-01 |
| Stage2-vs-Stage4 |
1.113760E-01 |
| Stage3-vs-Stage4 |
7.807000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.411500E-02 |
| Normal-vs-AfricanAmerican |
8.109400E-01 |
| Normal-vs-Asian |
5.390300E-02 |
| Caucasian-vs-AfricanAmerican |
1.180210E-01 |
| Caucasian-vs-Asian |
7.801200E-01 |
| AfricanAmerican-vs-Asian |
1.026780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.702600E-03 |
| Normal-vs-Female |
2.628200E-02 |
| Male-vs-Female |
9.834500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.174300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.143560E-02 |
| Normal-vs-Age(61-80Yrs) |
1.421800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.913700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.233600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.519400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.096400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.722800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.003800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.816650E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.009400E-01 |
| Classical-VS-Follicular |
3.30990013175381E-10 |
| Classical-VS-Other |
8.451900E-02 |
| Classical-VS-Normal |
3.404600E-01 |
| Tall-VS-Follicular |
1.31690000004792E-06 |
| Tall-VS-Other |
2.736400E-02 |
| Tall-VS-Normal |
9.290800E-01 |
| Follicular-VS-Other |
7.291200E-01 |
| Follicular-VS-Normal |
1.33180000361222E-08 |
| Other-VS-Normal |
2.253500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.615300E-04 |
| Normal-vs-N1 |
4.204000E-02 |
| N0-vs-N1 |
4.082000E-01 |
|
|
